US$ 200 million investment in PharmEasy

JSA advised B Capital in respect of its primary and secondary investment in API Holdings Private Limited (PharmEasy), a pre-IPO stage company engaged in the business of inter alia wholesale trade of pharmaceutical, nutraceutical and FMCG products and providing healthcare solutions using technology. The investment also saw participation from other marquee investors. The total amount raised by the Company in the primary round was approximately US$ 200 million. PharmEasy intends to use the proceeds of the round for its general corporate purposes, to enlarge its footprint in business and making further investments.

The fund raise was raised for organic and inorganic expansion of the company.

JSA team comprised Lead Partner – Manvinder Singh, Senior Associate – Anant Mishra, and Associate – Vishakha Singh.